A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

IsraelRecruitingPHASE3

Conditions

Diffuse Large B-Cell Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Banner MD Anderson Cancer Center ( Site 0165), Gilbert, Arizona, United States

    Study coordinator · 480-256-6444
  • Banner MD Anderson Cancer Center - University Medical Center Phoenix ( Site 0167), Phoenix, Arizona, United States

    Study coordinator · 480-256-6444
  • The University of Arizona Cancer Center - North Campus ( Site 0124), Tucson, Arizona, United States

    Study coordinator · 520-621-5497
  • Providence Medical Foundation-Oncology ( Site 0168), Fullerton, California, United States

    Study coordinator · 714-446-5900
  • MemorialCare Health System - Long Beach Medical Center ( Site 9559), Long Beach, California, United States

    Study coordinator · 652-241-9755
  • Cancer Blood and Specialty Clinic ( Site 0109), Los Alamitos, California, United States

    Study coordinator · 562-200-0203
  • Cedars-Sinai Medical Center ( Site 0115), Los Angeles, California, United States

    Study coordinator · 310-423-3277
  • Pacific Hematology Oncology Associates ( Site 0131), San Francisco, California, United States

    Study coordinator · 415-923-3012
  • Lutheran Hospital - Cancer Centers of Colorado ( Site 0180), Golden, Colorado, United States

    Study coordinator · 303-403-6381
  • Clermont Oncology Center ( Site 0182), Clermont, Florida, United States

    Study coordinator · 352-242-1366
  • Bioresearch Partner ( Site 0157), Hialeah, Florida, United States

    Study coordinator · 833-489-4968
  • Orlando Health Cancer Institute ( Site 0169), Ocoee, Florida, United States

    Study coordinator · 321-843-7497
  • Mid Florida Hematology and Oncology Center ( Site 0172), Orange City, Florida, United States

    Study coordinator · 386-774-1223
  • Cancer Care Specialists of Illinois ( Site 0152), O'Fallon, Illinois, United States

    Study coordinator · 618-416-7970
  • Fort Wayne Medical Oncology and Hematology ( Site 0149), Fort Wayne, Indiana, United States

    Study coordinator · 260-436-0800
  • Cotton O'Neil Cancer Center ( Site 0108), Topeka, Kansas, United States

    Study coordinator · 785-478-9495
  • University of Kentucky ( Site 0106), Lexington, Kentucky, United States

    Study coordinator · 859-257-6006
  • Norton Women's and Children's Hospital-Norton Cancer Institute - St. Matthews ( Site 0163), Louisville, Kentucky, United States

    Study coordinator · 502-899-3366
  • CHRISTUS St. Frances Cabrini Hospital Center for Cancer Care ( Site 0184), Alexandria, Louisiana, United States

    Study coordinator · 318-448-6917
  • American Oncology Partners, P.A. ( Site 0185), Bethesda, Maryland, United States

    Study coordinator · 301-571-2016
  • Karmanos Cancer Institute ( Site 0174), Detroit, Michigan, United States

    Study coordinator · 800-527-6266
  • Corewell Health ( Site 0130), Grand Rapids, Michigan, United States

    Study coordinator · 616-486-6180
  • The University of Mississippi Medical Center ( Site 0161), Jackson, Mississippi, United States

    Study coordinator · 601-984-5601
  • Circuit Clinical - SSM Health Cancer Care DePaul ( Site 0166), Bridgeton, Missouri, United States

    Study coordinator · 636-673-3083
  • Truman Medical Center ( Site 0122), Kansas City, Missouri, United States

    Study coordinator · 816-404-4418
  • Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana ( Site 0178), Billings, Montana, United States

    Study coordinator · 406-238-6685
  • OptumCare Cancer Care ( Site 0121), Las Vegas, Nevada, United States

    Study coordinator · 702-724-8787
  • Comprehensive Cancer Centers of Nevada ( Site 0113), Las Vegas, Nevada, United States

    Study coordinator · 702-622-9699
  • New York Oncology Hematology, P.C. ( Site 0129), Albany, New York, United States

    Study coordinator · 518-262-6696
  • Icahn School of Medicine at Mount Sinai ( Site 0164), New York, New York, United States

    Study coordinator · 212-241-6500
  • Sanford Health Roger Maris Cancer Center ( Site 0189), Fargo, North Dakota, United States

    Study coordinator · 701-234-6161
  • Prisma Health - Upstate ( Site 0158), Greenville, South Carolina, United States

    Study coordinator · 864-679-3900
  • Sanford Cancer Center ( Site 0143), Sioux Falls, South Dakota, United States

    Study coordinator · 605-328-8000
  • The University of Tennessee Medical Center ( Site 0142), Knoxville, Tennessee, United States

    Study coordinator · 865-305-9000
  • Center for Oncology and Blood Disorders ( Site 0153), Houston, Texas, United States

    Study coordinator · 713-301-8964
  • Houston Methodist Cancer Center ( Site 0154), Houston, Texas, United States

    Study coordinator · 713-363-8009
  • University of Virginia Cancer Center ( Site 0138), Charlottesville, Virginia, United States

    Study coordinator · 434-243-7773
  • Virginia Cancer Institute ( Site 0148), Richmond, Virginia, United States

    Study coordinator · 804-287-3000
  • Blue Ridge Cancer Care ( Site 0132), Roanoke, Virginia, United States

    Study coordinator · 540-982-0237
  • Vista Oncology ( Site 4201), Olympia, Washington, United States

    Study coordinator · 360-413-8880
  • SSM Health Dean Medical Group ( Site 0140), Madison, Wisconsin, United States

    Study coordinator · 608-410-2700
  • Clinica Adventista Belgrano ( Site 0309), Caba., Buenos Aires, Argentina

    Study coordinator · +5491140141500
  • Instituto de Investigaciones Clinicas Mar del Plata ( Site 0306), Mar del Plata, Buenos Aires, Argentina

    Study coordinator · +542234963224
  • Hospital Universitario Austral ( Site 0307), Pilar, Buenos Aires, Argentina

    Study coordinator · +541158239252
  • Hospital Aleman ( Site 0301), Buenos Aires, Buenos Aires F.D., Argentina

    Study coordinator · +541148232574
  • Fundacion Estudios Clinicos ( Site 0311), Rosario, Santa Fe Province, Argentina

    Study coordinator · +54 (0341) 2221472
  • C.I.C.E. 9 de Julio ( Site 0305), San Miguel de Tucumán, Tucumán Province, Argentina

  • Hospital Italiano de Buenos Aires ( Site 0304), CABA, Argentina

    Study coordinator · (011) 4959-0550
  • Clinica EL Castaño ( Site 0312), San Juan, Argentina

  • Townsville University Hospital ( Site 3006), Douglas, Queensland, Australia

    Study coordinator · +61744333549
  • Royal Adelaide Hospital ( Site 3001), Adelaide, South Australia, Australia

    Study coordinator · 0870745898
  • Grampians Health ( Site 3003), Ballarat, Victoria, Australia

    Study coordinator · +61353204000
  • Northern Hospital ( Site 3002), Melbourne, Victoria, Australia

    Study coordinator · +61384058000
  • Royal Perth Hospital-Haematology ( Site 3004), Perth, Western Australia, Australia

    Study coordinator · +61864775013
  • AZ Sint-Maarten, Campus Leopoldstraat 2 ( Site 1102), Mechelen, Antwerpen, Belgium

    Study coordinator · +32(0)15/89.10.10
  • ASBL CHU Helora - Hôpital de Mons - Site Kennedy ( Site 1103), Mons, Hainaut, Belgium

    Study coordinator · +3265413744
  • CEONC ( Site 0412), Cascavel, Paraná, Brazil

    Study coordinator · 049988422678
  • Hospital Erasto Gaertner ( Site 0401), Curitiba, Paraná, Brazil

    Study coordinator · +5541999846033
  • Liga Norte Riograndense Contra o Cancer ( Site 0407), Natal, Rio Grande do Norte, Brazil

    Study coordinator · +5584999278442
  • CEPEN - Centro de Pesquisa e Ensino em Oncologia de Santa Catarina ( Site 0403), Florianópolis, Santa Catarina, Brazil

    Study coordinator · +554833804828
  • Hope ( Site 0413), Ribeirão Preto, São Paulo, Brazil

    Study coordinator · +55 16 98813-0059
  • Clinica Advanze ( Site 0411), São Carlos, São Paulo, Brazil

    Study coordinator · 55163371-1320
  • F. F. R. M. São Jose do Rio Preto ( Site 0404), SJRP, São Paulo, Brazil

    Study coordinator · +55 17 99788 6883
  • Hospital Paulistano ( Site 0406), São Paulo, Brazil

    Study coordinator · +551131411083
  • Hospital das Clinicas FMUSP ( Site 0402), São Paulo, Brazil

    Study coordinator · +5511975458304
  • Queen Elizabeth II Health Sciences Centre ( Site 0207), Halifax, Nova Scotia, Canada

    Study coordinator · 902-473-4642
  • Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0208), Hamilton, Ontario, Canada

    Study coordinator · 9053879495
  • Lakeridge Health - The R.S. McLaughlin Durham Regional Cancer Centre (MDRCC) ( Site 0206), Oshawa, Ontario, Canada

    Study coordinator · 9055768711
  • Sunnybrook Research Institute ( Site 0204), Toronto, Ontario, Canada

    Study coordinator · 4164804662
  • Biocenter ( Site 0510), Concepción, Biobio, Chile

    Study coordinator · +56412858421
  • IC La Serena Research ( Site 0504), La Serena, Coquimbo Region, Chile

    Study coordinator · +56958646664
  • Oncocentro Valdivia ( Site 0506), Valdivia, Los Ríos Region, Chile

    Study coordinator · +56632632200
  • Centro de Estudios Clínicos SAGA ( Site 0508), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56991612199
  • FALP ( Site 0501), Santiago, Region M. de Santiago, Chile

    Study coordinator · +5622712 8000
  • Clinica Inmunocel ( Site 0503), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56224376600
  • Clínica RedSalud Vitacura ( Site 0512), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56 223954046
  • Bradfordhill ( Site 0502), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56229490970
  • Centro de Investigaciones ( Site 0511), Viña del Mar, Valparaiso, Chile

    Study coordinator · +56323245375
  • Anhui Provincial Cancer Hospital ( Site 3124), Hefei, Anhui, China

    Study coordinator · +8655165327666
  • Peking University Third Hospital ( Site 3102), Beijing, Beijing Municipality, China

    Study coordinator · 010-82266699
  • Beijing Cancer Hospital ( Site 3101), Beijing, Beijing Municipality, China

    Study coordinator · 010-88121122
  • Chongqing Cancer Hospital ( Site 3113), Chongqing, Chongqing Municipality, China

    Study coordinator · 023-65301682
  • Fujian Provincial Cancer Hospital. ( Site 3119), Fuzhou, Fujian, China

    Study coordinator · 059162752082
  • The First Affiliated Hospital of Xiamen University ( Site 3120), Xiamen, Fujian, China

    Study coordinator · +8605922137255
  • Sun Yat-sen University Cancer Center ( Site 3121), Guangzhou, Guangdong, China

    Study coordinator · 020-87343765
  • Zhujiang Hospital of Southern Medical University ( Site 3122), Guangzhou, Guangdong, China

    Study coordinator · 020-62782020
  • Affiliated Cancer Hospital of Guangxi Medical University ( Site 3123), Nanning, Guangxi, China

    Study coordinator · 0771-5323002
  • The Affiliated Hospital of Guizhou Medical University ( Site 3112), Guiyang, Guizhou, China

    Study coordinator · 0851-86740793
  • Hubei Cancer Hospital ( Site 3125), Wuhan, Hubei, China

    Study coordinator · 027-87670003
  • Affiliated Hospital of Nantong University ( Site 3117), Nantong, Jiangsu, China

    Study coordinator · +8618252100915
  • Jiangxi Cancer Hospital ( Site 3118), Nanchang, Jiangxi, China

    Study coordinator · 0791-88317256
  • The First Hospital Of Jilin University ( Site 3103), Changchun, Jilin, China

    Study coordinator · 0431-88782222
  • Shandong Cancer Hospital ( Site 3108), Jinan, Shandong, China

    Study coordinator · 053167626063
  • LinYi Cancer Hospital ( Site 3104), Linyi, Shandong, China

    Study coordinator · +865398127192
  • Fudan University Shanghai Cancer Center ( Site 3115), Shanghai, Shanghai Municipality, China

    Study coordinator · +862164175590
  • Shanxi Cancer Hospital ( Site 3106), Taiyuan, Shanxi, China

    Study coordinator · 0351-4651606
  • 1st Affil Hosp of Med College of Xi'an Jiaotong University ( Site 3107), Xi’an, Shanxi, China

    Study coordinator · 029-85324094
  • Sichuan Cancer Hospital. ( Site 3111), Chengdu, Sichuan, China

    Study coordinator · 02885420243
  • West China Hospital, Sichuan University ( Site 3110), Chengdu, Sichuan, China

    Study coordinator · 028-85422114
  • Institute of Hematology and Blood Diseases Hosp CAMS&PUMC ( Site 3105), Tianjin, Tianjin Municipality, China

    Study coordinator · 022 23608030
  • Yunnan Province Cancer Hospital ( Site 3109), Kunming, Yunnan, China

    Study coordinator · 0871-68185656
  • The First Affiliated Hospital, Zhejiang Medical University ( Site 3116), Hangzhou, Zhejiang, China

    Study coordinator · 0571-87236668
  • Hospital Pablo Tobon Uribe ( Site 0604), Medellín, Antioquia, Colombia

    Study coordinator · +57 604 4459753
  • Hospital Universitario San Ignacio ( Site 0607), Bogotá, Bogota D.C., Colombia

  • IMAT S.A.S ( Site 0603), Montería, Departamento de Córdoba, Colombia

    Study coordinator · +57 604 7832333
  • Oncologos del Occidente ( Site 0601), Pereira, Risaralda Department, Colombia

    Study coordinator · 573002558656
  • Fundación Valle del Lili ( Site 0602), Cali, Valle del Cauca Department, Colombia

    Study coordinator · 3158971414
  • University College Hospital, Department of Haematology ( Site 1303), Aarhus, Central Jutland, Denmark

    Study coordinator · +45 78455848
  • Regionshospitalet Gødstrup ( Site 1301), Herning, Central Jutland, Denmark

    Study coordinator · +45 78430000
  • Aalborg University Hospital ( Site 1302), Aalborg, North Denmark, Denmark

    Study coordinator · +4597662238
  • Odense Universitetshospital ( Site 1304), Odense, Region Syddanmark, Denmark

    Study coordinator · +45 6541 1152
  • Centre Antoine-Lacassagne ( Site 1514), Nice, Alpes-Maritimes, France

    Study coordinator · +33492031000
  • Hopital Saint Louis, Centre Hospitalier de La Rochelle ( Site 1511), La Rochelle, Charente-Maritime, France

    Study coordinator · +33546458867.
  • CHU Dijon Bourgogne ( Site 1516), Dijon, Cote-d Or, France

    Study coordinator · +33380669237
  • CHU GRENOBLE ALPES ( Site 1518), La Tronche, Isere, France

    Study coordinator · +33476765755
  • Centre Hospitalier Universitaire de Limoges - Hôpital Dupuytren ( Site 1512), Limoges, Limousin, France

    Study coordinator · +33555056651
  • Centre Hospitalier Régional Metz Thionville - Hôpital de Mercy ( Site 1515), Metz, Moselle, France

    Study coordinator · +33387553363
  • Centre Hospitalier de Dunkerque ( Site 1513), Dunkirk, Nord, France

    Study coordinator · +330328285633
  • Centre Hospitalier Universitaire Estaing ( Site 1508), Clermont-Ferrand, Puy-de-Dome, France

    Study coordinator · 33473752291
  • Centre Hospitalier de la Cote Basque ( Site 1509), Bayonne, Pyrenees-Atlantiques, France

    Study coordinator · +33533788254
  • Centre Henri Becquerel ( Site 1517), Rouen, Seine-Maritime, France

    Study coordinator · 02.76.67.30.45
  • HIA Sainte Anne ( Site 1506), Toulon, Var, France

    Study coordinator · +33483162506
  • Centre Hospitalier d'Avignon ( Site 1505), Avignon, Vaucluse, France

    Study coordinator · 33432759330
  • CHD Vendee ( Site 1502), La Roche-sur-Yon, Vendee, France

    Study coordinator · +33251446173
  • Institut Curie - site Saint-Cloud ( Site 1501), Saint-Cloud, Île-de-France Region, France

    Study coordinator · 01 47 11 17 92
  • Evangelismos General Hospital of Athens ( Site 1602), Athens, Attica, Greece

    Study coordinator · 0030 2132041721
  • General Hospital of Athens "Laiko"-Hematology Department ( Site 1603), Athens, Attica, Greece

    Study coordinator · 0030 2136060981
  • Attikon University General Hospital of Athens ( Site 1604), Athens, Attica, Greece

    Study coordinator · 0030 2105832318
  • University General Hospital of Alexandroupoli ( Site 1601), Alexandroupoli, Evros, Greece

    Study coordinator · 0030 2551353739
  • MEDI-K ( Site 0701), Guatemala City, Guatemala

    Study coordinator · +50222912323
  • CELAN,S.A ( Site 0702), Guatemala City, Guatemala

    Study coordinator · +502 55275016
  • Cen Integral Onco Gastro y Hemato Onco Guatemala S.A. ( Site 0703), Guatemala City, Guatemala

    Study coordinator · +502 30147611
  • Princess Margaret Hospital ( Site 3202), Hong Kong, Hong Kong

    Study coordinator · 85229901111
  • Queen Mary Hospital ( Site 3201), Hong Kong, Hong Kong

    Study coordinator · 85222553838
  • Semmelweis University-Belgyógyászati és Hematológiai Klinika ( Site 1703), Budapest, Hajdú-Bihar, Hungary

    Study coordinator · +3614591500
  • Debreceni Egyetem Klinikai Kozpont ( Site 1702), Debrecen, Hajdú-Bihar, Hungary

    Study coordinator · +3652255601
  • Szabolcs Szatmár Bereg Vármegyei Oktatókórház ( Site 1704), Nyíregyháza, Szabolcs-Szatmár-Bereg, Hungary

    Study coordinator · +3642599700/1060
  • Tolna Vármegyei Balassa János Kórház ( Site 1710), Szekszárd, Tolna County, Hungary

    Study coordinator · +36 74 501 603
  • Orszagos Onkologiai Intezet ( Site 1705), Budapest, Hungary

    Study coordinator · +36 1 224 8600 #3775
  • Carmel Hospital ( Site 1903), Haifa, Israel

    Study coordinator · 04-8250844
  • Hadassah Medical Center ( Site 1901), Jerusalem, Israel

    Study coordinator · 97226778180
  • Sourasky Medical Center ( Site 1904), Tel Aviv, Israel

    Study coordinator · 9723-6973782
  • Poria Medical Center ( Site 1902), Tiberias, Israel

    Study coordinator · 972-4-662759
  • Fondazione IRCCS San Gerardo dei Tintori ( Site 2008), Monza, Lombardy, Italy

    Study coordinator · +390392333539
  • IRCCS Crob ( Site 2002), Rionero in Vulture, Potenza, Italy

    Study coordinator · +390972726685
  • Istituto di Candiolo IRCCS - Fondazione del Piemonte per l'Oncologia ( Site 2010), Candiolo, Torino, Italy

    Study coordinator · +390119933250
  • AOU delle Marche Ospedali Riuniti di Ancona ( Site 2011), Ancona, Italy

    Study coordinator · +390715964562
  • Azienda Ospedaliera Spedali Civili di Brescia-Hemathology ( Site 2001), Brescia, Italy

    Study coordinator · +390303995438
  • IRCCS Ospedale San Raffaele ( Site 2012), Milan, Italy

    Study coordinator · +39 02 2643 7649
  • IEO Istituto Europeo di Oncologia ( Site 2009), Milan, Italy

    Study coordinator · +39 02 94371079
  • Azienda Ospedaliero Universitaria Maggiore della Carità ( Site 2004), Novara, Italy

    Study coordinator · +3903213733127
  • Az. Osp. Ospedali Riuniti VILLA SOFIA-CERVELLO ( Site 2005), Palermo, Italy

    Study coordinator · +390916802773
  • Ospedale Santa Maria delle Croci ( Site 2006), Ravenna, Italy

    Study coordinator · +390544285722
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore ( Site 2003), Roma, Italy

    Study coordinator · 00390630154180
  • Nagoya University Hospital ( Site 3309), Nagoya, Aichi-ken, Japan

    Study coordinator · +81-52-741-2111
  • National Cancer Center Hospital East ( Site 3303), Kashiwa, Chiba, Japan

    Study coordinator · +81-4-7133-1111
  • National Hospital Organization Shikoku Cancer Center ( Site 3321), Matsuyama, Ehime, Japan

    Study coordinator · +81-89-999-1111
  • Kobe City Medical Center General Hospital ( Site 3318), Kobe, Hyōgo, Japan

    Study coordinator · +81-78-302-4321
  • Kanazawa University Hospital ( Site 3308), Kanazawa, Ishikawa-ken, Japan

    Study coordinator · +81-76-265-2000
  • Tokai University Hospital ( Site 3302), Isehara, Kanagawa, Japan

    Study coordinator · +81-463-93-1121
  • Tohoku University Hospital ( Site 3301), Sendai, Miyagi, Japan

    Study coordinator · +81-22-717-7000
  • Kindai University Hospital ( Site 3310), Sakai, Osaka, Japan

    Study coordinator · +81-72-288-7222
  • Saitama Medical University Hospital ( Site 3305), Iruma-gun, Saitama, Japan

    Study coordinator · +81-49-276-1111
  • Juntendo University Hospital ( Site 3307), Bunkyo, Tokyo, Japan

    Study coordinator · +81-3-3813-3111
  • Tokyo Metropolitan Komagome Hospital ( Site 3323), Bunkyo, Tokyo, Japan

    Study coordinator · +81-3-3823-2101
  • University of Yamanashi Hospital ( Site 3320), Chūō, Yamanashi, Japan

    Study coordinator · +81-55-273-1111
  • Chiba Cancer Center ( Site 3314), Chiba, Japan

    Study coordinator · +81-43-264-5431
  • Kyushu University Hospital ( Site 3313), Fukuoka, Japan

    Study coordinator · +8192-641-1151
  • Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital ( Site 3322), Hiroshima, Japan

    Study coordinator · +81-82-241-3111
  • University Hospital,Kyoto Prefectural University of Medicine ( Site 3315), Kyoto, Japan

    Study coordinator · +81-75-251-5111
  • University of Miyazaki Hospital ( Site 3319), Miyazaki, Japan

    Study coordinator · +81-985-85-1510
  • Okayama University Hospital ( Site 3311), Okayama, Japan

    Study coordinator · +81-86-223-7151
  • Osaka Metropolitan University Hospital ( Site 3317), Osaka, Japan

    Study coordinator · +81-6-6645-2121
  • Yamagata University Hospital ( Site 3312), Yamagata, Japan

    Study coordinator · +81-23-633-1122
  • Queen Elizabeth Hospital ( Site 3405), Kota Kinabalu, Sabah, Malaysia

    Study coordinator · +6088517555
  • Sarawak General Hospital ( Site 3402), Kuching, Sarawak, Malaysia

    Study coordinator · +6082276666
  • Hospital Miri ( Site 3403), Miri, Sarawak, Malaysia

    Study coordinator · +6085460600
  • Sunway Medical Centre ( Site 3406), Petaling Jaya, Selangor, Malaysia

    Study coordinator · +60386011080
  • Hospital Ampang ( Site 3404), Selangor Darul Ehsan, Selangor, Malaysia

    Study coordinator · +60342896559
  • CIMAB SA de CV ( Site 0807), Torreón, Coahuila, Mexico

  • Grupo Ollin Care ( Site 0806), Pachuca, Hidalgo, Mexico

  • Health Pharma Professional Research S.A. de C.V. ( Site 0801), Mexico City, Mexico City, Mexico

    Study coordinator · +52 5575864856
  • Centro de Infusion Superare ( Site 0804), Mexico City, Mexico City, Mexico

    Study coordinator · 52 5552646440
  • Centro de Investigacion Clinica Chapultepec ( Site 0803), Morelia, Michoacán, Mexico

    Study coordinator · 52 4431478545
  • Hospital Universitario ""Dr. Jose Eleuterio Gonzalez"" ( Site 0802), Monterrey, Nuevo León, Mexico

    Study coordinator · 52 8183486136
  • Centro de Investigacion Clinica de Oaxaca ( Site 0805), Oaxaca City, Mexico

    Study coordinator · 52 9515473137
  • Albert Schweitzer Ziekenhuis ( Site 2103), Dordrecht, South Holland, Netherlands

    Study coordinator · +31(0)786523013
  • Meander Medisch Centrum ( Site 2101), Amersfoort, Utrecht, Netherlands

    Study coordinator · +31(0)338502129
  • Clínicas AUNA Sede Chiclayo ( Site 0904), Chiclayo, Lambayeque, Peru

    Study coordinator · 51 74748333 Ext 7832
  • INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS ( Site 0901), Surquillo, Muni Metro de Lima, Peru

  • Clínica San Felipe ( Site 0906), Lima, Peru

    Study coordinator · 511 2039900 Ext 131
  • Hospital Nacional Edgardo Rebagliati Martins ( Site 0903), Lima, Peru

    Study coordinator · +51991895682
  • Hospital Nacional Dos De Mayo ( Site 0905), Lima, Peru

    Study coordinator · +51944464618
  • Pratia Onkologia Wroclaw ( Site 2211), Wroclaw, Lower Silesian Voivodeship, Poland

    Study coordinator · 502 278 782
  • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie ( Site 2201), Warsaw, Masovian Voivodeship, Poland

  • Wojewódzki Szpital Specjalistyczny im. J. Korczaka w Słupsku ( Site 2210), Słupsk, Pomeranian Voivodeship, Poland

    Study coordinator · 59 84 60 390
  • Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 2208), Gliwice, Silesian Voivodeship, Poland

    Study coordinator · +48322789794
  • Pratia Onkologia Katowice ( Site 2204), Katowice, Silesian Voivodeship, Poland

    Study coordinator · +48327462500
  • Szpital Kliniczny Ministerstwa Spraw Wewnętrznych i Administracji z Warmińsko-Mazurskim Centrum Onko ( Site 2205), Olsztyn, Warmian-Masurian Voivodeship, Poland

    Study coordinator · +48895398428
  • Unidade Local de Saude de Braga - Hospital de Braga ( Site 2306), Braga, Portugal

    Study coordinator · +351253 027 249
  • Unidade Local de Saude de Santa Maria - Hospital de Santa Maria ( Site 2308), Lisbon, Portugal

    Study coordinator · +351 217 805 000
  • Instituto Portugues de Oncologia Do Porto Francisco Gentil E.P.E. ( Site 2302), Porto, Portugal

    Study coordinator · +351 22 508 4000
  • BRCR Global - Mayaguez ( Site 1003), Mayagüez, Puerto Rico

    Study coordinator · 1 561 437 6038
  • Auxilio Mutuo Cancer Center ( Site 1001), San Juan, Puerto Rico

    Study coordinator · 787 758 2000
  • Spitalul Clinic Colțea ( Site 2401), Bucharest, Bucharest, Romania

    Study coordinator · +40213874100
  • Institutul Oncologic Cluj ( Site 2404), Cluj-Napoca, Cluj, Romania

    Study coordinator · +40264598362
  • Centrul de Diagnostic si Tratament Oncologic Brasov ( Site 2402), Brasov, Romania

    Study coordinator · +40268 960
  • Spital Judetean Sibiu ( Site 2405), Sibiu, Romania

    Study coordinator · +40269215050
  • National University Hospital ( Site 3702), Singapore, Central Singapore, Singapore

    Study coordinator · 6569082222
  • National Cancer Centre Singapore ( Site 3701), Singapore, Central Singapore, Singapore

    Study coordinator · 6564368000
  • LIFE GROENKLOOF-Mary Potter Cancer Centre ( Site 2506), Pretoria, Gauteng, South Africa

    Study coordinator · +27 (0)12 346 6701
  • Netcare Pretoria East Hospital ( Site 2502), Pretoria, Gauteng, South Africa

    Study coordinator · +27129932555
  • Haemalife ( Site 2501), Cape Town, Western Cape, South Africa

    Study coordinator · +27 21 900 6277
  • Groote Schuur Hospital ( Site 2504), Cape Town, Western Cape, South Africa

    Study coordinator · +27214043077
  • National Cancer Center- Center for Hemotologic malignancy ( Site 3806), Goyang-si, Kyonggi-do, South Korea

    Study coordinator · 8231-920-1505
  • Pusan National University Hospital ( Site 3804), Busan, Pusan-Kwangyokshi, South Korea

    Study coordinator · +8251-240-7839
  • Chungnam National University Hospital ( Site 3801), Daejeon, Taejon-Kwangyokshi, South Korea

    Study coordinator · 82422806922
  • Severance Hospital, Yonsei University Health System ( Site 3802), Seoul, South Korea

  • Asan Medical Center ( Site 3803), Seoul, South Korea

    Study coordinator · +82230105940
  • Samsung Medical Center ( Site 3807), Seoul, South Korea

  • St.Mary's H., Youido ( Site 3805), Seoul, South Korea

    Study coordinator · +82237791049
  • Hospital Universitario Virgen Macarena ( Site 2608), Seville, Andalusia, Spain

    Study coordinator · 34955054993
  • ICO L Hospitalet ( Site 2601), L'Hospitalet de Llobregat, Barcelona, Spain

    Study coordinator · 932607750
  • H. Insular de Gran Canaria ( Site 2606), Las Palmas de Gran Canaria, Las Palmas, Spain

    Study coordinator · 0034928441738
  • Hospital Universitario Puerta de Hierro ( Site 2615), Majadahonda, Madrid, Spain

    Study coordinator · 34911916000
  • Hospital General Universitario Dr. Balmis ( Site 2604), Alicante, Valenciana, Comunitat, Spain

    Study coordinator · 34965913727
  • Hospital del Mar ( Site 2610), Barcelona, Spain

    Study coordinator · 34932483343
  • Hospital General Universitario 12 de Octubre ( Site 2605), Madrid, Spain

    Study coordinator · +34605532453
  • Hospital Universitario La Paz ( Site 2611), Madrid, Spain

    Study coordinator · 34912071518
  • Hospital Virgen de la Victoria ( Site 2609), Málaga, Spain

    Study coordinator · 0034951032508
  • Hospital Universitario Miguel Servet ( Site 2607), Zaragoza, Spain

    Study coordinator · 34976765500
  • Kantonspital Baden ( Site 2703), Baden, Canton of Aargau, Switzerland

    Study coordinator · 0041564862111
  • Cantonal Hospital St.Gallen-Oncology & Hematology ( Site 2702), Sankt Gallen, Canton of St. Gallen, Switzerland

    Study coordinator · 41714941111
  • Ospedale Regionale Bellinzona e Valli ( Site 2701), Bellinzona, Canton Ticino, Switzerland

    Study coordinator · +41 91 811 89 31
  • Ospedale Italiano Lugano (OIL) ( Site 2705), Lugano, Canton Ticino, Switzerland

    Study coordinator · 0041918118612
  • Chang Gung Memorial Hospital - Linkou Branch ( Site 3903), Taoyuan City, Taoyuan, Taiwan

    Study coordinator · +88633281200x2555
  • Chang Gung Memorial Hospital at Kaohsiung ( Site 3905), Kaohsiung City, Taiwan

    Study coordinator · 886-7-7317123
  • National Cheng Kung University Hospital ( Site 3902), Tainan, Taiwan

    Study coordinator · +88662353535x4620
  • National Taiwan University Hospital ( Site 3901), Taipei, Taiwan

    Study coordinator · +88623123456
  • Mackay Memorial Hospital ( Site 3908), Taipei, Taiwan

  • Tri-Service General Hospital ( Site 3906), Taipei, Taiwan

    Study coordinator · +886287927208x12903
  • Faculty of Medicine Siriraj Hospital ( Site 4001), Bangkoknoi, Bangkok, Thailand

    Study coordinator · +6624194448
  • Chulalongkorn University ( Site 4003), Pathumwan, Bangkok, Thailand

    Study coordinator · +6622564000
  • Maharaj Nakorn Chiang Mai Hospital ( Site 4002), Muang, Chiang Mai, Thailand

    Study coordinator · +6653935488
  • Ondokuz Mayıs Universitesi ( Site 2806), Korfez Mahallesi, Samsun, Turkey (Türkiye)

    Study coordinator · +905052722289
  • Namık Kemal University Medical Faculty ( Site 2807), Suleymanpasa, Tekirdas, Turkey (Türkiye)

    Study coordinator · +905326347632
  • Baskent Universitesi Adana Dr. Turgut Noyan UAM ( Site 2809), Adana, Turkey (Türkiye)

  • Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastırma Hastanesi ( Site 2803), Ankara, Turkey (Türkiye)

    Study coordinator · +90 (0312) 336 09 09
  • Hacettepe Universite Hastaneleri ( Site 2810), Ankara, Turkey (Türkiye)

    Study coordinator · 05322276104
  • Ankara University Faculty of Medicine ( Site 2801), Ankara, Turkey (Türkiye)

    Study coordinator · +903125956593
  • Antalya Egitim ve Arastirma Hastanesi ( Site 2805), Antalya, Turkey (Türkiye)

  • Göztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesi ( Site 2804), Istanbul, Turkey (Türkiye)

    Study coordinator · 0090 532 408 9525
  • MNPE ClinCenter of Oncology,Hematology,Transplantology and Palliative Care of CherkasyRegCouncil ( Site 2904), Cherkasy, Cherkasy Oblast, Ukraine

    Study coordinator · +38 047 2370025
  • Communal non-profit enterprise "Regional clinical hospital of Ivano-Frankivsk Regional Council" ( Site 2906), Ivano-Frankivsk, Ivano-Frankivsk Oblast, Ukraine

    Study coordinator · +380342 528029
  • Khmelnytskyi Regional Hospital ( Site 2907), Khmelnytskiy, Khmelnytskyi Oblast, Ukraine

    Study coordinator · +380382649001
  • Institute of Blood Pathology and Transfusion Medicine AMS Ukraine ( Site 2903), Lviv, Lviv Oblast, Ukraine

    Study coordinator · +380322373917
  • SNPE National Cancer Institute ( Site 2902), Kyiv, Ukraine

    Study coordinator · 380443346418
  • Universal Clinic Oberig ( Site 2908), Kyiv, Ukraine

  • SI National Research Center of Radiation Medicine, Hematology, Oncology ( Site 2901), Kyiv, Ukraine

  • Public Non-Profit Enterprise Kyiv City Clinical Hospital #9 under the Executive Body of Kyiv City Co ( Site 2905), Kyiv, Ukraine

    Study coordinator · +38 044 4671989
Study leads
  • Medical Director

    Study Director

    Merck Sharp & Dohme LLC